MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-94-103$20.00
Mol Pharmacol 64:94-103, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Harmon, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.
Right arrow Articles by Harmon, C. M.

Molecular Determination of Agouti-Related Protein Binding to Human Melanocortin-4 Receptor

Yingkui Yang, Min Chen, Yumei Lai, Ira Gantz, Aydin Yagmurlu, Keith E. Georgeson, and Carroll M. Harmon

Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama (Y.Y, M.C., A.Y., K.E.G., C.M.H.); and Department of Surgery, University of Michigan, Ann Arbor, Michigan (Y.L., I.G.)

Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin-4 receptor (MC4R) that functions in the hypothalamic control of feeding behavior. Our previous studies have suggested that in addition to exoloops 2 and 3, several transmembrane domains of MC4R may be important for AGRP binding. However, the detailed molecular basis of MC4R domains in AGRP binding is presently unclear. The present studies were designed to determine the specific contribution of MC4R exoloops and transmembrane domains to AGRP binding by using chimeric receptor constructs of the human melanocortin-1 receptor (hMC1R), a receptor that is not inhibited by AGRP, and the human MC4R (hMC4R), a receptor that is potently inhibited by AGRP. Our results indicate that substitutions of the second and third extracellular loops of the MC4R with homologous domains of the MC1R dramatically decreased AGRP 87–132 binding affinity, but did not affect AGRP 110–117 binding affinity. In contrast, cassette substitutions of the third or fourth transmembrane domain of the MC4R with the homologous domain of the MC1R resulted in a substantial decrease of AGRP 87–132 binding affinity and loss of AGRP 110–117 binding affinity. These data suggest that the AGRP fragment 110–117 has no binding sites at exoloops of hMC4R and that transmembrane domains of MC4R may play an important role in AGRP 110–117 binding and function, whereas the exoloops do not. The second and third extracellular loops of MC4R are important for AGRP 87–132 N-terminal binding, whereas the third and fourth transmembrane domains of hMC4R are crucial for AGRP 110–117 binding.


Received January 2, 2003; accepted April 7, 2003

Address correspondence to: Dr. Yingkui Yang, Division of Pediatric Surgery, University of Alabama at Birmingham, 300 ACC, 1600 7th Avenue South, Birmingham, AL 35233. E-mail: ying-kui.yang{at}ccc.uab.edu




This article has been cited by other articles:


Home page
BioinformaticsHome page
Y. Bromberg and B. Rost
Comprehensive in silico mutagenesis highlights functionally important residues in proteins
Bioinformatics, August 15, 2008; 24(16): i207 - i212.
[Abstract] [PDF]


Home page
EndocrinologyHome page
L. Huo, H. Munzberg, E. A. Nillni, and C. Bjorbaek
Role of Signal Transducer and Activator of Transcription 3 in Regulation of Hypothalamic trh Gene Expression by Leptin
Endocrinology, May 1, 2004; 145(5): 2516 - 2523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. K. Rana
New Insights into G-Protein-Coupled Receptor Signaling from the Melanocortin Receptor System
Mol. Pharmacol., July 1, 2003; 64(1): 1 - 4.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics